TOKYO (Reuters) - Japan's Astellas Pharma <4503.T> loses U.S. patent protection on Prograf, a major transplant drug, on Tuesday, amid worries that its market share may erode more quickly than expected ...
ZURICH, Aug 11 (Reuters) - Swiss drugmaker Novartis AG said on Tuesday its Sandoz business has launched the first generic version of Prograf capsules, an immunosuppresant to help prevent rejection of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback